Dendritic cell tumor

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:98289C96.4
Who is this for?
Show terms as
39Specialists8Treatment centers

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026A Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247) in Study Participants With HRD-negative Epithelial Ovarian Cancer

Peking University Third Hospital — NA

TrialNOT YET RECRUITING
Feb 2026An Antibody-armored Dendritic Cell in Patients With Solid Tumors

Shanghai Cell Therapy Group Co.,Ltd — PHASE1

TrialRECRUITING
Dec 2025Immune Cell Therapy for Advanced Solid Tumors

Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. — PHASE1, PHASE2

TrialNOT YET RECRUITING
Aug 2025Personalized Vaccine for TNBC Immunotherapy

Universidad Nacional de Colombia — PHASE1

TrialNOT YET RECRUITING
Jun 2025Prostate Cancer Vaccines

Shenzhen Geno-Immune Medical Institute — PHASE1, PHASE2

TrialRECRUITING
Jun 2024Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

H. Lee Moffitt Cancer Center and Research Institute — EARLY_PHASE1

TrialRECRUITING
May 2024Engineered Dendritic Cell Vaccines for Multiple Myeloma

Shenzhen Geno-Immune Medical Institute — PHASE1

TrialRECRUITING
Sep 2023DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs

Zhen-Yu Ding — EARLY_PHASE1

TrialRECRUITING
Aug 2023A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

H. Lee Moffitt Cancer Center and Research Institute — PHASE1

TrialRECRUITING
Apr 2023Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors

The First Affiliated Hospital of Nanchang University — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Dendritic cell tumor.

View clinical trials →

Clinical Trials

View all trials with filters →

No actively recruiting trials found for Dendritic cell tumor at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Dendritic cell tumor community →

Specialists

Showing 25 of 39View all specialists →
BG
Boon Cher Goh
Specialist
PI on 3 active trials
AM
Ashley Ghiaseddin, MD
GAINESVILLE, FL
Specialist
PI on 3 active trials1 Dendritic cell tumor publication
SM
Steven A Rosenberg, M.D.
Specialist
PI on 19 active trials
DM
Daniel Landi, MD
DURHAM, NC
Specialist
PI on 7 active trials
SM
Swati Naik, MD
MEMPHIS, TN
Specialist
PI on 1 active trial
SM
Susan K. Parsons, MD, MRP
Specialist
PI on 1 active trial
NM
Nirali N Shah, M.D.
Specialist
PI on 7 active trials
PM
Paulina Velasquez, MD
IRVINE, CA
Specialist
PI on 1 active trial
JM
Joselle Cook, M.B.B.S.
Specialist
PI on 1 active trial
NM
Nora Bennani, M.D.
Specialist
PI on 1 active trial
HM
Hoyoung M Maeng, M.D.
FRAMINGHAM, MA
Specialist
PI on 5 active trials
CM
Chitra M. Hosing, MD
HOUSTON, TX
Specialist
PI on 6 active trials
KP
Kelly McConnell, PhD
Specialist
PI on 2 active trials
TC
Timothy F Cloughesy
LOS ANGELES, CA
Specialist
PI on 2 active trials1 Dendritic cell tumor publication
FP
Frank Aboubakar Nana, MD; PhD
Specialist
PI on 1 active trial
AF
Annick Desjardins, MD, FRCPC
DURHAM, NC
Specialist
PI on 14 active trials
JM
John Yu, MD
Specialist
PI on 2 active trials
MM
Michal Lotem, MD
Specialist
PI on 2 active trials
JM
John Kirkwood, MD
Specialist
PI on 3 active trials
JD
Jolanda de Vries, Prof. dr.
Specialist
PI on 2 active trials
RM
Robert Israel, MD
Specialist
PI on 7 active trials
JP
Jose Luis Perez Gracia, MD, PhD
NAPA, CA
Specialist
PI on 1 active trial
MF
Mustafa Khasraw, MBChB, MD, FRCP, FRACP
NEW YORK, NY
Specialist
PI on 3 active trials
JM
John F DiPersio, MD,PhD
SAINT LOUIS, MO
Specialist
PI on 1 active trial
FD
Felix Keil, Prim. Univ. Prof. Dr
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Dendritic cell tumor.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Dendritic cell tumorForum →

No community posts yet. Be the first to share your experience with Dendritic cell tumor.

Start the conversation →

Latest news about Dendritic cell tumor

Disease timeline:

New recruiting trial: Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

A new clinical trial is recruiting patients for Dendritic cell tumor

New recruiting trial: Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer

A new clinical trial is recruiting patients for Dendritic cell tumor

New recruiting trial: Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia

A new clinical trial is recruiting patients for Dendritic cell tumor

New recruiting trial: Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors

A new clinical trial is recruiting patients for Dendritic cell tumor

New recruiting trial: An Antibody-armored Dendritic Cell in Patients With Solid Tumors

A new clinical trial is recruiting patients for Dendritic cell tumor

New recruiting trial: Engineered Dendritic Cell Vaccines for Multiple Myeloma

A new clinical trial is recruiting patients for Dendritic cell tumor

New recruiting trial: Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

A new clinical trial is recruiting patients for Dendritic cell tumor

New recruiting trial: Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer

A new clinical trial is recruiting patients for Dendritic cell tumor

New recruiting trial: dENdritic Cell Therapy Combined With SURgEry in Mesothelioma

A new clinical trial is recruiting patients for Dendritic cell tumor

New recruiting trial: DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs

A new clinical trial is recruiting patients for Dendritic cell tumor

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Dendritic cell tumor

Which specialists treat Dendritic cell tumor?

25 specialists and care centers treating Dendritic cell tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.